Longevity research investigates cellular senescence, mitochondrial function, telomere biology, DNA repair, and age-related tissue decline. These are the peptides most cited in current preclinical longevity literature — what they do, what's been studied, and how researchers combine them.
Epitalon (also spelled Epithalon) is a tetrapeptide (Ala-Glu-Asp-Gly) derived from the bovine pineal gland peptide epithalamin. Russian research led by Khavinson and Anisimov has examined it in animal aging models since the 1980s, making it one of the longest-studied longevity peptides.
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme central to cellular energy metabolism. Not a peptide technically, but it is studied alongside peptides in longevity research. Age-related NAD+ decline has been characterized in multiple tissues and species. Research explores roles in DNA repair (via PARP1), mitochondrial function (via sirtuins), and cellular stress resistance.
GHK-Cu is a tripeptide (glycyl-histidyl-lysine) bound to a copper atom. It was first identified in the 1970s by Pickart as a growth-promoting factor in plasma. Research has examined its effects on gene expression — studies using DNA microarrays show GHK-Cu modulates over 4,000 genes in cultured cells, including genes related to tissue repair, inflammation, and cellular reprogramming.
Thymosin Alpha-1 is a 28-amino-acid peptide isolated from thymic tissue. Research in immunosenescence (age-related immune decline) has examined its role in T-cell function, dendritic cell activation, and immune system reconstitution in aged animal models. Pharmaceutical-grade forms are used clinically in some countries for specific immune indications.
SS-31 (also known as Elamipretide in pharmaceutical development) is a mitochondria-targeted tetrapeptide that selectively binds cardiolipin on the inner mitochondrial membrane. Research has examined its effects on mitochondrial bioenergetics, reactive oxygen species production, and cristae structure preservation in aged tissue models.
Researchers often combine peptides from different mechanistic categories to study multi-pathway effects in aging models:
Mitochondrial co-factor replenishment paired with telomere-focused research. NAD+ engages sirtuin/PARP pathways; Epitalon engages telomere biology. Complementary, non-overlapping mechanisms.
Two mitochondrial angles — SS-31 targets the membrane/cristae structure, NAD+ provides metabolic co-factor support. Common stack in mitochondrial aging models.
Tissue regeneration focus. GHK-Cu modulates broad gene expression; TB-500 drives cell migration. Used in models of age-related tissue decline.
Immune-system-focused aging research. The pre-dosed TA-1 + Thymulin Complex is available at $115.98.
The most-studied peptides in longevity research are Epitalon (telomere biology), GHK-Cu (gene expression modulation), Thymosin Alpha-1 (immune aging), and SS-31 (mitochondrial membrane). NAD+ (technically a coenzyme, not a peptide) is almost universally cited in longevity literature for its role in sirtuins and DNA repair.
Anisimov's research group has published multiple studies in CBA and SHR rat strains showing lifespan extension with Epitalon administration. These are rodent models — results in research animals do not constitute evidence for effects in humans. The peptide is classified research-use only. Larger-scale replication in other labs and species is an ongoing research frontier.
NAD+ pharmacokinetics are actively studied. Direct NAD+ administration, NAD+ precursors (nicotinamide riboside, nicotinamide mononucleotide), and small-molecule sirtuin activators all have research literature. Administered NAD+ has been studied in preclinical models for raising tissue NAD+ levels, but the relative efficacy vs precursors vs activators remains an active research question. Researchers should consult the primary literature for their specific model.
Yes. Combining peptides from non-overlapping mechanisms is standard practice in longevity research. Common stacks include NAD+ with Epitalon (mitochondrial + telomere), SS-31 with NAD+ (two mitochondrial angles), and TA-1 with Thymulin (immune aging). The combined approach reflects the multi-hallmark nature of aging biology.
Yes. All compounds listed here are legal to acquire for research purposes in the United States. They are classified as research-use-only — not intended for human consumption in this form. Licensed researchers and physicians may acquire them for preclinical research protocols and practice-of-medicine use.
Every SMART MD batch is verified by three independent U.S. laboratories — HPLC analysis (99%+ average purity), mass spectrometry for molecular weight confirmation, and LAL endotoxin assay. Lot-specific COAs are publicly verifiable at smartmdpeptides.com/verify before you buy.
Check the COA before you buy. Compare SMART MD's documentation to any other supplier.